Skip to main content
. 2018 Dec 1;49(1):29–36. doi: 10.1093/jjco/hyy179

Figure 1.

Figure 1.

Disposition of the Japanese subset in the FLAURA study. DCO, data cutoff. aAmong patients who requested dispensing of crossover treatment with osimertinib, five patients provided dosing information with osimertinib in the electronic case report form.